CNS Delivery Frontiers, Enabling Oligonucleotide Therapeutics for Neurological Disorders

• Latest innovations in crossing the blood–brain barrier with oligonucleotide drugs
• Design considerations for enabling safe and effective CNS delivery

Speakers:

Cody Desjardins

Senior Director

Dyne Therapeutics